1. Thailand Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Winnergy Medical Public Company Limited

Winnergy Medical Public Company Limited

1.20
THB
-0.03
(-2.44%)
0.04EPS
17.63P/E
296.00MMarket Cap
Winnergy Medical Public Company Limited
SET:WINMED
(Stock Exchange of Thailand)

Recent

price

1.20

P/E

ratio

17.63

div

yld

1.04%

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
THB
- -
0.96
1.29
1.23
1.33
1.5
1.76
1.6
1.64
1.62
1.75
Revenue per Share
- -
0.01
-0.02
0.11
0.13
0.18
0.15
0.08
0.07
0.04
0.04
Basic EPS, GAAP
- -
- -
0.12
0.14
-0.11
-0.17
-0.35
-0.14
-0.21
-0.13
0.08
Free Cash Flow per Basic Share
- -
- -
0.01
0.02
0.11
0.12
0.06
0.06
0.03
0.02
0.01
Dividend per Share
0.03
0.01
0.16
0.23
0.47
1.43
1.49
1.51
1.58
1.59
1.6
Book Value per Share
0.03
0.01
0.16
0.2
0.44
1.4
1.44
1.45
1.49
1.49
1.49
Tangible Book Value per Share
400
400
400
400
400
359
400
400
400
400
400
Basic Weighted Avg Shares
- -
383
514
492
531
539
703
639
654
647
700
Sales/Revenue/Turnover
- -
2.29
12.93
11.5
13.1
10.59
8.27
5.33
3.74
1.3
1.45
Operating Margin (%)
- -
- -
21
19
23
34
41
45
50
53
52
Depreciation Expense
- -
2
-6
45
52
65
61
31
29
15
17
Net Income, GAAP
- -
50.28
26.27
27.79
16.71
9.64
12.73
13.09
13.88
20.45
24.3
Effective Tax Rate (%)
- -
0.61
-1.25
9.19
9.72
12.11
8.63
4.79
4.47
2.34
2.4
Profit Margin (%)
12
7
-95
1
19
288
266
243
250
254
236
Working Capital
- -
- -
- -
- -
51
38
64
86
158
141
139
LT Debt
13
5
-3
91
189
572
595
604
632
635
640
Total Equity
- -
6.48
30.36
17.78
18.8
10.19
7.28
3.63
4.41
2.87
1.47
Return on Invested Capital (%)
- -
6.34
-28.17
28.16
19.46
13.41
9.51
4.74
4.42
2.87
2.79
Return on Capital (%)
- -
26.88
-18.87
58.95
36.94
17.14
10.4
5.11
4.73
2.39
2.64
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
221
264
242
LT Borrowings
103
96
89
LT Finance Leases
38
52
51
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
400
400
Market Capitalization
396
356
296

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
592
608
579
Cash, Cash Equivalents & STI
19
14
10
Accounts Receivable, Net
224
280
314
Inventories
192
173
153
Total Current Liabilities
337
359
343
Payables & Accruals
98
73
79
ST Debt
221
264
242
Deferred Revenue
17
23
23

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
42.74%
0.5%
Free Cash Flow
- -
24.12%
-40.3%
Net Income, GAAP
- -
-16.55%
-48.15%
Sales/Revenue/Turnover
- -
4.85%
-1.12%
Total Cash Common Dividend
- -
-24.34%
-16.1%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
141
141
188
185
654
2025
158
151
156
182
647
2026
152
209
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.03
0.03
0.07
2025
0.02
- -
- -
0.01
0.04
2026
0.01
0.02
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.03
- -
- -
0.03
2025
- -
0.02
- -
- -
0.02
2026
- -
0.01
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Winnergy Medical Public Company Limited (WINMED.BK), founded in 2004 and headquartered in Bangkok, Thailand, imports and distributes high-technology medical and diagnostic equipment and products throughout Thailand, primarily serving hospitals, clinics, and healthcare institutions in the women healthcare, blood banking, blood safety, cell therapy, and molecular diagnostics segments. Core offerings include women's health products such as Down syndrome and genetic screening tests, pregnancy monitoring solutions including fetal fibronectin tests for preterm birth risk, cervical cancer screening kits like ThinPrep Pap Tests and ThinPrep 2000 Processors, vaginal health assays for bacterial vaginosis and candida, sexual health tests for gonorrhea and chlamydia, newborn screening panels for congenital infections and spinal muscular atrophy, and prenatal non-invasive prenatal testing (NIPS); blood banking equipment for blood quality testing and fractionation; blood safety products encompassing nucleic acid testing (NAT) for pathogen inactivation and blood infection detection; cell and molecular technology solutions for stem cell therapy, immunotherapy, tissue regeneration, graft engineering, and contamination analysis; as well as consumer products like mosquito and insect trapping devices under the AND brand; complemented by services through Winmed Health Center focused on health promotion, disease prevention, and equitable access to quality care. The company, formerly Winnergy Medical Co., Ltd., changed its name to Winnergy Medical Public Company Limited in September 2020 upon listing on the Stock Exchange of Thailand, listed successfully in 2021 as a key milestone, and pursues strategic initiatives including partnerships such as with Kanchanaburi Provincial Administrative Organization for a free health caravan project, participation in the 39th Annual Scientific Meeting of the Royal College of Obstetricians and Gynecologists of Thailand, and receipt of the Outstanding Investor Relations Award at SET Awards 2024.